Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000892569-03-001296
Filing Date
2003-05-14
Accepted
2003-05-14 16:51:22
Documents
6
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT #2 a87286a2e10vkza.htm 10-K/A 221600
3 EXHIBIT 10.30 a87286a2exv10w30.txt EX-10.30 89262
4 EXHIBIT 10.33 a87286a2exv10w33.txt EX-10.33 209107
5 EXHIBIT 99.1 a87286a2exv99w1.txt EX-99.1 1130
6 EXHIBIT 99.2 a87286a2exv99w2.txt EX-99.2 1137
8 GRAPHIC a87286a2a8728603.gif GRAPHIC 12514
  Complete submission text file 0000892569-03-001296.txt   536961
Mailing Address 15279 ALTON PARKWAY 100 IRVINE CA 92618
Business Address 15279 ALTON PARKWAY 100 IRVINE CA 92618 9497886000
ISTA PHARMACEUTICALS INC (Filer) CIK: 0000930553 (see all company filings)

EIN.: 330511719 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-31255 | Film No.: 03699782
SIC: 2835 In Vitro & In Vivo Diagnostic Substances